CIM Investment Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,172
Closed -$275K 311
2021
Q2
$275K Hold
3,172
0.09% 225
2021
Q1
$262K Buy
+3,172
New +$262K 0.08% 233